Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players√Ę‚ā¨‚ĄĘ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Auto Injector Companies

Auto-injector companies specialize in developing and manufacturing devices that enable easy and self-administered injection of medication. These devices are designed to enhance convenience, accuracy, and safety in delivering a variety of pharmaceuticals. Auto-injectors typically feature a pre-filled cartridge or syringe and an automated injection mechanism. They are user-friendly, often requiring minimal training for patients to self-administer medications, including those for chronic conditions like diabetes, rheumatoid arthritis, or allergic reactions. These companies play a crucial role in improving patient adherence to treatment plans, reducing the need for healthcare professional intervention in routine injections, and enhancing overall patient experience. Auto-injectors are widely used for emergency situations, such as epinephrine auto-injectors for severe allergic reactions. These companies continually innovate, focusing on ergonomic design, connectivity features, and ensuring the compatibility of their devices with a range of medications, contributing to advancements in home-based healthcare and patient empowerment.

Auto-Injector CompaniesLatest Auto-Injectors Companies Update



  • Jan 2023: Key issues for global healthcare systems are addressed by DCA Design International's user-focused PiccoJect, an autoinjector that offers excellence via simplicity for Haselmeier. It is Haselmeier's cutting-edge, user-focused, small, feature-rich autoinjector platform, created to tackle major healthcare issues. The growing incidence of chronic illnesses is one such issue. PiccoJect has been specifically designed to deliver "biologics," typically administered by injection and increasingly subcutaneously. Various treatments are among the most promising and effective ones for treating various conditions.




  • Nov 2023:To advance up to seven programs, Bayer and Recursion Pharmaceuticals revealed a change in their partnership that would concentrate on oncology. Recursion might receive payments of up to $1.5 billion, contingent upon milestones and royalties on net sales. A concomitant agreement also revealed that Recursion has agreed to pay Tempus $160 million over five years for priority access to almost 20 petabytes of data, including patient health records, DNA, and RNA de-identified for cancer purposes. To support this and other collaborations, Recursion also revealed that it was acquiring over 500 NVIDIA H100 Tensor Core GPUs to supplement the 300 A100 GPUs, therefore quadrupling the processing capability of its BioHive-1 on-premise supercomputer. According to Recursion, BioHive-1 would rank in the world's top 50 most potent supercomputers with this upgrade.


List of Auto-Injectors Companies in the market

  • Merck KGaA

  • AbbVie Inc

  • Antares Pharma

  • Eli Lilly and Company

  • Teva Pharmaceutical¬†

  • Amgen¬†

  • Johnson & Johnson

  • GlaxoSmithKline plc¬†

  • Becton, Dickinson and Company

Auto-Injector Market Overview


The auto-injector market is expected to reach USD 8.80 billion by 2032 at 14.2% CAGR during the forecast period 2023-2032. The auto-injector is a type of syringe that has pre-dosage drugs. It triggers the right amount of drugs in the syringe. Injecting a measured amount of drugs into a sliding motion is an exceptional feature of this device. Auto-injectors are useful for personal purposes. It is an exceptional injector for self-administration. Also, it is beneficial for epinephrine and migraine conditions. For medical and urgent treatments the usage of an auto-injector is essential. There are plenty of benefits of auto-injectors.


Few advantages of the auto-injectors are it is a suitable syringe for individuals with phobia disorders. It lessens the accidents of the needle getting stuck into the body. Also, it is useful for proper dosage quantity and injection effectiveness. The auto-injectors are receiving plenty of awareness in recent years. Today, due to lockdown many are rapidly adopting auto-injectors.


Many patients and their families learn self-administration. It saves effort and time of visiting hospitals for very injections. With the auto-injectors, arthritis patients, multiple sclerosis and other chronic disease patients can benefits. Patients with chronic illness require everyday injections. With the help of auto-injectors, the accuracy and effectiveness of the medicine are high.


Covid analysis 


The outbreak of covid 19 has lead to a global health crisis. The health sector is more during this period. Demand for non-essential medical services has reduced massively. The number of patients visiting hospitals for treatment other than covid 19 reduced to 40%. Patients are delaying the treatment and injections required for chronic illness. It has a declining impact on the auto-injector market.


There is a slowdown in the launch of treatments required for chronic illness. Due to these factors, the auto injector’s market growth is slowing down. However, the pharmaceutical company market is key end-users for auto-injectors. It is accelerating the demand for auto inject in the current year. The development of pharmaceutical companies is creating a positive impact on the auto-injector market. Overall the auto-injector market analysis trend remains positive during this period. 


Auto-Injector Market Trends 



  • Crucial market drivers¬†


The rise of anaphylaxis is severe in many regions. It is a dangerous food reaction that causes deadly allergies. One out of 1000 people in the population has an anaphylaxis reaction. Further, the patients suffering from this disorder is high during anesthesia. Epinephrine is the primary treatment available for anaphylaxis. The pharmaceutical companies are raising their production of auto-injectors that contain epinephrine. 


The pharma companies are raising the launch of advanced auto-injectors. The need for injector caps, injection dosage and audible click detection is improving in the new models. The availability of these injectors is growing during the forecast period. Earlier, the auto injector’s cases were fewer. However, in many patients, it is effortlessly available for home use. Increased adoption and use of auto-injectors will grow the auto-injector market size. The growth of the geriatric population is another demand driving factor of auto-injector market. auto-injector market profitability will increase due to these factors. 



  • Market growth opportunities¬†


Due to the covid 19 pandemic, new protocols are created for a patient visiting the hospitals. During non-emergency cases, the healthcare industry is taking preventive measures. These protocols help to stop the spread of the covid virus. The need to limit the number of patients visiting the hospital for non-emergency purposes is rising growth opportunities. The presence of home injection is highly prevalent among many patients.


Especially, the patient with chronic illnesses finds these auto-injectors highly beneficial. Also, the increasing awareness about this injector is another factor leading to growth opportunities. Rheumatoid arthritis is another crucial reason for the growth of the auto-injector market. Patients with a severe allergy do not need to delay the treatment. With the help of auto-injectors, quick treatment is possible. In the covid 19, the application of auto-injectors has expanded. In the upcoming years, more patients and end-users will have a high demand for auto-injectors. The auto-injector market expansion rate for the market is immense in the forecast year. All these will lead exceptional auto-injector market growth opportunities. 



  • The market restraints¬†


The traditional injections are invasive and painful. It is leading to more demand for clinical drugs, oral, nasal and other modes of treatment. The oral route of medicines is preferred by half the population. The ease of use, convenience and cost are some of the benefits of clinical drugs. It is a safe and acceptable form of medication for many. Today, digital pharmacy services are expanding rapidly. It is a reliable form of delivering drugs to patients.


The growth of drug delivery market restraints the growth of the auto-injector market. The anxiety about needles is less due to these drugs. There is a decline in injection treatment in many regions. It is changing the customer preference towards the painless drug market. From children to chronic illness patients prefer fewer pain meds of treatment. The anxiety of needles is the key factor restraining auto-injector market growth. 



  • The market challenges¬†


There are different types of chronic illnesses requiring daily injections. However, the versatility of the illness creates different requirements for auto-injectors. The injection capacity, dosage, length and thickness require being different for each of the medications. These factors lead to different types of auto-injectors.


 It is a challenging aspect of the market. The non-availability of proper auto-injectors and lack of product versatility can have a declining effect on the auto-injector market. The OEM lacks the knowledge of manufacturing multiple drugs. The key players are taking efforts to eradicate these market challenges. With more research, the market is trying to cope with this challenge. 



  • Cumulative growth analysis¬†


The overall growth rate of the auto-injector market is stable in the forecast period. There are few factors that continually propel the demand of the market. The rising urgency of injection in allergic cases is stirring the demand for the auto-injector market. Due to chronic illness, the adoption of auto-injectors is tremendous in many regions. The awareness about self-administration is leaving to more profits for the market.


Further, the key players are increasing the availability of these auto-injectors. Due to convenience and ease of access many users prefer auto-injectors. The anxiety about the injection and growth of digital pharmacy services is a retaining factor of auto-injector market. Overall the growth trend of the auto-injector market is promising for the forecast period. 



  • The value chain analysis¬†


The Asia Pacific market is expected to outgrow other regional players in the forecast period. The demand for auto-injectors is high in this region. The immense growth of diabetes patients is raising the demand for the product. Further, the health care infrastructure is developing at an exponential pace.


It leads to more manufacture of auto-injectors. Home care and self-administration in chronic illnesses is surging in this region. For non-urgent cases, many patients and their families learn to use auto injectors. The presence of top auto-injector market companies is advantageous for market growth. There is constant development and high demand for auto-injectors in Asia pacific region. 


Auto-Injector Market Segment 


Auto-Injector therapy Outlook

  • Anaphylaxis

  • Rheumatoid Arthritis

  • Diabetes

  • Multiple Sclerosis


Auto-Injector type Outlook

  • Reusable auto-injectors¬†

  • Disposable auto-injectors¬†


Auto-Injector administration Outlook

  • Intramuscular¬†

  • Subcutaneous¬†


Auto-Injector end-user Outlook



  • Ambulatory care¬†

  • Home care¬†

  • Hospital care¬†


Auto-Injector geography Outlook

  • Middle East¬†

  • Asia pacific¬†

  • Europe¬†

  • North America¬†


Competitive landscape 


The competition in the auto-injector market is rising in the forecast period. The key players will lead to more research and innovation. Market acquisitions, expansion and partnerships are part of the competitive landscape. New product launches and segment expansions are key strategies of the market players. 


Regional analysis 


The auto-injector market is fragmented into Asia Pacific, Europe, Middle East and North America. The Asia Pacific will hold the maximum auto-injector market share. The investment for the health industry is rising in Asia pacific. It will fuel the production of auto-injectors in Asia pacific.


Through partnerships with local pharmacies, the region is expanding its market. North America is the next region with the highest market demand. The adoption of auto-injectors is rapid in this region. Also, the high spending power of customers will lead to more growth of auto-injectors. It is a market with the highest profitability rate in the forecast period. 


The key players of the auto-injector market are 



  • Merck KGaA

  • AbbVie Inc

  • Antares Pharma

  • Eli Lilly and Company


  • Teva Pharmaceutical¬†

  • Amgen¬†

  • Johnson & Johnson

  • GlaxoSmithKline plc¬†

  • Becton, Dickinson and Company


Recent developments 



  • The key players of the market are signing new projects for the production of auto-injectors in the middle east.¬†¬†

  • The key players are introducing auto-injection delivery systems in many regions.¬†


Report overview 



  • Market overview highlights¬†

  • Analysis based upon COVID 19

  • Explanation upon the Market Dynamics

  • Value chain analysis

  • Market segmentation overview

  • The regional analysis

  • Competitive landscape analysis

  • Recent Developments

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.